GaoRong Capital
AI overview
Sign in and the AI will write an overview from our coverage.
Headlines · 2
- Active Technology Raises RMB 464 Million for Invasive Brain-Computer Interface
Active Technology announced a RMB 464 million angel-plus financing round led by GaoRong Capital, SDIC Pilot, and Shanghai Technology Innovation Capital, according to 36Kr. The proceeds will support invasive brain-computer interface research and development, clinical translation, and industrialization. Existing investors DaoTong Capital, BGI PineHill, and Inno Capital also increased their investments.
36氪快讯 · 🔥 0 - Chinese medical firms queue up to invest in AI and semiconductor funds
A report by VCBeat (carried by 36Kr and TMTPost) says that after Andon Health's "medical main business plus tech investment" model gained traction, a group of listed Chinese medical companies — including Yuwell Medical, EasyDiagnosis, Intco Medical, Yifan Pharmaceutical and Amoytop Biotech — have recently subscribed to funds focused on AI and semiconductors, with names such as Gaorong Changying Fund and the new Monolith fund backed by medical firms. The report says Andon Health's portfolio includes Moonshot AI, MetaX, StepFun and Zhengxing Innovation, and that its net profit rose 233.66% year on year in the first half of 2026. Specific moves include Yuwell Hong Kong putting HK$94.9 million into CFTC fund shares and a plan to commit up to 500 million yuan to a fund managed by SMIC Capital, while Intco, Amoytop and Yifan invested as limited partners. The report also cites an industry figure warning that AI and semiconductor asset valuations are already high and that increasing tech exposure now may not be the best window.
36氪 人工智能 · 🔥 0
Experience and discussion from the community
Share my GaoRong Capital experienceAsk about GaoRong Capital
Nobody has shared their experience with GaoRong Capital yet.